Moreover, Kaplan-Meier analysis indicated that CRC patients with high FOXS1 expression had significantly worse overall survival (OS) than patients with low FOXS1 expression (P < 0.01, Fig. 1B). This evidence concerns the gene FOXS1 and colorectal carcinoma.